Lunch

Chairperson:
07 Jul 2018
12:30 - 13:40
Level 6, Mandarin Grand Ballroom, Mandarin Orchard

Lunch

1230 – 1340 Lunch
1245 – 1315 Lunch Symposium
(Sponsored by DCH Auriga Singapore)
Evolution of Infliximab Biosimilar: CT-P13
Key Clinical Evidence of CT-P13: From Concept to Clinical Practice
– 3.4 CD RCT (Switching Data for 54 weeks)
– SC Trial
1315 – 1340 Lunch (continuation) and Viewing of Posters and Exhibitions